MAPT and frontotemporal dementia: Another important finding is the observation of clinically diagnosed AD families carrying previously reported and likely novel pathogenic mutations in GRN and MAPT. Mutations in these genes are typically associated with frontotemporal lobar degeneration [18], [19], but have been previously reported in clinically diagnosed AD cases [20]–[28].